Description
AtosibanisanantagoNISTatoxytocinandvasopressinreceptors,exhibitingtocolyticactivity.Atosibanisclinicallyusedtodecreaseuterinecontractilityinthepreventionofpretermbirth.
AtosibanisanantagoNISTatoxytocinandvasopressinreceptors,exhibitingtocolyticactivity.Atosibanisclinicallyusedtodecreaseuterinecontractilityinthepreventionofpretermbirth.
| CasNo. | 914453-95-5 |
|---|---|
| Purity | ≥95% |
| Formula | C43H67N11O12S2 |
| FormulaWt. | 994.2 |
| IUPACName | aceticacid;(2S)-N-[(2S)-5-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxopentan-2-yl]-1-[(4R,7S,13S,16R)-7-(2-amino-2-oxoethyl)-13-[(2S)-butan-2-yl]-16-[(4-ethoxyphenyl)methyl]-10-[(1R)-1-hydroxyethyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide |
| Appearance | Whitetooffwhitepowder |
| StoreTemp | -20°C |
|---|---|
| ShipTemp | Ambient |
| InfoSheet | A7657InfoSheetPDF |
|---|
UstaIM,KhalilA,NassarAH.Oxytocinantagonistsforthemanagementofpretermbirth:areview.AmJPerinatol.2011Jun;28(6):449-60.PMID:21170825.
PierzynskiP.OxytocinandvasopressinV(1A)receptorsasnewtherapeutictargetsinassistedreproduction.ReprodBiomedOnline.2011Jan;22(1):9-16.PMID:21130036.